1. Home
  2. PTGX vs RNST Comparison

PTGX vs RNST Comparison

Compare PTGX & RNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTGX
  • RNST
  • Stock Information
  • Founded
  • PTGX 2006
  • RNST 1904
  • Country
  • PTGX United States
  • RNST United States
  • Employees
  • PTGX N/A
  • RNST N/A
  • Industry
  • PTGX Biotechnology: Pharmaceutical Preparations
  • RNST Major Banks
  • Sector
  • PTGX Health Care
  • RNST Finance
  • Exchange
  • PTGX Nasdaq
  • RNST Nasdaq
  • Market Cap
  • PTGX 3.3B
  • RNST 3.3B
  • IPO Year
  • PTGX 2016
  • RNST N/A
  • Fundamental
  • Price
  • PTGX $53.00
  • RNST $38.52
  • Analyst Decision
  • PTGX Strong Buy
  • RNST Buy
  • Analyst Count
  • PTGX 9
  • RNST 6
  • Target Price
  • PTGX $67.11
  • RNST $42.20
  • AVG Volume (30 Days)
  • PTGX 923.4K
  • RNST 541.9K
  • Earning Date
  • PTGX 08-05-2025
  • RNST 07-22-2025
  • Dividend Yield
  • PTGX N/A
  • RNST 2.27%
  • EPS Growth
  • PTGX N/A
  • RNST 31.26
  • EPS
  • PTGX 0.86
  • RNST 3.20
  • Revenue
  • PTGX $207,801,000.00
  • RNST $710,265,000.00
  • Revenue This Year
  • PTGX N/A
  • RNST $40.84
  • Revenue Next Year
  • PTGX $53.09
  • RNST $13.45
  • P/E Ratio
  • PTGX $61.48
  • RNST $12.09
  • Revenue Growth
  • PTGX N/A
  • RNST 15.97
  • 52 Week Low
  • PTGX $32.50
  • RNST $26.97
  • 52 Week High
  • PTGX $60.60
  • RNST $39.63
  • Technical
  • Relative Strength Index (RSI)
  • PTGX 53.99
  • RNST 66.56
  • Support Level
  • PTGX $49.38
  • RNST $37.38
  • Resistance Level
  • PTGX $51.51
  • RNST $38.91
  • Average True Range (ATR)
  • PTGX 2.02
  • RNST 0.79
  • MACD
  • PTGX -0.39
  • RNST 0.21
  • Stochastic Oscillator
  • PTGX 46.09
  • RNST 91.18

About PTGX Protagonist Therapeutics Inc.

Protagonist Therapeutics Inc is a clinical-stage biopharmaceutical company having a proprietary technology platform that enables the discovery and development of novel constrained peptide-based drug candidates to address medical needs. Its pipeline products include Rusfertide (PTG-300) and JNJ-2113.

About RNST Renasant Corporation

Renasant Corp operates as a holding company for Renasant Bank, a Mississippi banking corporation, and its subsidiary, Renasant Insurance, Inc. It has three reportable segments: Community banks, Insurance, and Wealth management. With its Community banks segment, the company provides a range of financial services to individuals and small businesses. Its Insurance segment is an insurance agency providing commercial and personal insurance through third-party carriers. The Wealth management segment provides a range of services, including money management and retirement planning. The majority of the company's revenue is driven by lending activities in its community banks segment.

Share on Social Networks: